… Atypical lobular hyperplasia (ALH) and lobular carcinoma in … cells originating in the terminal
duct lobular units (TDLUs), with or … In the core biopsy setting, pathologists are encouraged to …

… Atypical lobular hyperplasia was diagnosed when acini in a lobular unit had less than 50%
involvement by a monotonous population of epithelial cells showing classic lobular …

… With routine multidisciplinary management conferences where pathology and radiology
were … In their situation, a multidisciplinary approach does not appear to have been feasible. …

… Atypical ductal hyperplasia (ADH) and lobular carcinoma in situ (LCIS) may be associated
with a relatively high incidence of invasive carcinoma and ductal carcinoma in situ (DCIS) on …

… of lobular neoplasia (atypical lobular hyperplasia and non–pleomorphic lobular carcinoma in
situ… new diagnosis, after discussion at the multidisciplinary team meeting. All patients with a …

… lobular neoplasia of the breast (LN) was coined to group both atypical lobular hyperplasia
(ALH) and lobular … pure LN in the setting of radiologic-pathologic concordance is not required. …

… Observation after risk assessment and multidisciplinary input … For women with a history of
ADH or lobular hyperplasia and … cancer risk factors and input of the multidisciplinary team. …

… with a focus of atypical lobular hyperplasia (Fig. 9). Atypical lobular hyperplasia is a high-risk …
-pathology correlations for which a multidisciplinary team is helpful. Understanding the …

… encompasses both lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). …
This ensures that appropriate management decisions are made in a multidisciplinary setting…

… encompasses both lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). …
to be eligible for this approach after multidisciplinary team evaluation (66). Guidelines from …